Cryoport (CYRX) Liabilities and Shareholders Equity (2016 - 2025)
Cryoport (CYRX) has disclosed Liabilities and Shareholders Equity for 13 consecutive years, with $765.0 million as the latest value for Q4 2025.
- On a quarterly basis, Liabilities and Shareholders Equity rose 8.74% to $765.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.0 billion, a 5.85% decrease, with the full-year FY2025 number at $765.0 million, up 8.74% from a year prior.
- Liabilities and Shareholders Equity was $765.0 million for Q4 2025 at Cryoport, down from $774.3 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $1.1 billion in Q4 2021 to a low of $699.8 million in Q1 2025.
- A 5-year average of $901.7 million and a median of $897.6 million in 2024 define the central range for Liabilities and Shareholders Equity.
- Peak YoY movement for Liabilities and Shareholders Equity: skyrocketed 484.99% in 2021, then decreased 29.87% in 2024.
- Cryoport's Liabilities and Shareholders Equity stood at $1.1 billion in 2021, then decreased by 6.67% to $1.0 billion in 2022, then dropped by 7.8% to $957.7 million in 2023, then dropped by 26.55% to $703.5 million in 2024, then grew by 8.74% to $765.0 million in 2025.
- Per Business Quant, the three most recent readings for CYRX's Liabilities and Shareholders Equity are $765.0 million (Q4 2025), $774.3 million (Q3 2025), and $773.9 million (Q2 2025).